These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of 6 weeks of vitamin E administration on renal haemodynamic alterations following a single dose of neoral in healthy volunteers. Bárány P; Stenvinkel P; Ottosson-Seeberger A; Alvestrand A; Morrow J; Roberts JJ; Salahudeen AK Nephrol Dial Transplant; 2001 Mar; 16(3):580-4. PubMed ID: 11239035 [TBL] [Abstract][Full Text] [Related]
4. The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation. Madsen JK; Sørensen SS; Hansen HE; Pedersen EB Nephrol Dial Transplant; 1998 Sep; 13(9):2327-34. PubMed ID: 9761517 [TBL] [Abstract][Full Text] [Related]
5. Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. Perico N; Ruggenenti P; Gaspari F; Mosconi L; Benigni A; Amuchastegui CS; Gasparini F; Remuzzi G Transplantation; 1992 Jul; 54(1):56-60. PubMed ID: 1631945 [TBL] [Abstract][Full Text] [Related]
6. Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies. Pedersen EB; Madsen JK; Sørensen SS; Zachariae H Kidney Int Suppl; 1996 Jun; 55():S94-6. PubMed ID: 8743522 [TBL] [Abstract][Full Text] [Related]
7. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year. Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092 [TBL] [Abstract][Full Text] [Related]
8. Renal hemodynamic effects of L-arginine and sodium nitroprusside in heart transplant recipients. Koller-Strametz J; Wolzt M; Fuchs C; Putz D; Wisser W; Mensik C; Eichler HG; Laufer G; Schmetterer L Kidney Int; 1999 May; 55(5):1871-7. PubMed ID: 10231449 [TBL] [Abstract][Full Text] [Related]
9. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients? Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945 [TBL] [Abstract][Full Text] [Related]
10. Renal function in cyclosporine-treated pediatric renal transplant recipients in relation to gingival overgrowth. Wondimu B; Berg U; Modéer T Transplantation; 1997 Jul; 64(1):92-6. PubMed ID: 9233707 [TBL] [Abstract][Full Text] [Related]
12. Effects of the prostacyclin analogue iloprost on cyclosporin-induced renal hypoperfusion in stable renal transplant recipients. Hansen JM; Christensen NJ; Fogh-Andersen N; Strandgaard S Nephrol Dial Transplant; 1996 Feb; 11(2):340-6. PubMed ID: 8671790 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and renal function after conversion from standard to microemulsion formulation of cyclosporine in stable renal transplant patients. Gaspari F; Anedda MF; Signorini O; Amuchastegui SC; Perico N; Remuzzi G Transplant Proc; 1998 Aug; 30(5):1654-5. PubMed ID: 9723229 [No Abstract] [Full Text] [Related]
14. Fish oil and cyclosporin A-induced renal hypoperfusion in kidney-transplanted patients. Hansen JM; Høy CE; Strandgaard S Nephrol Dial Transplant; 1995; 10(9):1745-50. PubMed ID: 8559499 [TBL] [Abstract][Full Text] [Related]
15. Kidney function in cyclosporine-treated pediatric heart transplant recipients. Laine J; Jalanko H; Leijala M; Sairanen H; Holmberg C J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133 [TBL] [Abstract][Full Text] [Related]
16. Renal and systemic effects of atenolol and tertatolol in renal transplant recipients on cyclosporine A. Branten AJ; Hilbrands LB; van Hamersvelt HW; Koene RA; Huysmans FT Nephrol Dial Transplant; 1998 Feb; 13(2):423-6. PubMed ID: 9509456 [TBL] [Abstract][Full Text] [Related]